Confused? Buy or Sell in volatile market – Analyst report DarioHealth (NASDAQ:DRIO)

0
843

Earnings results for DarioHealth (NASDAQ:DRIO)

DarioHealth Corp. is expected* to report earnings on 11/12/2020 before market open. The report will be for the fiscal Quarter ending Sep 2020. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.84. The reported EPS for the same quarter last year was $-1.2.

DarioHealth last issued its earnings data on August 12th, 2020. The reported ($0.68) earnings per share for the quarter, topping the consensus estimate of ($1.54) by $0.86. The business had revenue of $1.79 million for the quarter, compared to the consensus estimate of $1.72 million. DarioHealth has generated ($8.00) earnings per share over the last year. DarioHealth has confirmed that its next quarterly earnings report will be published on Thursday, November 12th, 2020.

Analyst Opinion on DarioHealth (NASDAQ:DRIO)

3 Wall Street analysts have issued ratings and price targets for DarioHealth in the last 12 months. Their average twelve-month price target is $17.33, predicting that the stock has a possible upside of 58.73%. The high price target for DRIO is $25.00 and the low price target for DRIO is $10.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of “Buy.”

DarioHealth has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $17.33, DarioHealth has a forecasted upside of 58.7% from its current price of $10.92. DarioHealth has only been the subject of 2 research reports in the past 90 days.

Dividend Strength: DarioHealth (NASDAQ:DRIO)

DarioHealth does not currently pay a dividend. DarioHealth does not have a long track record of dividend growth.

Insiders buying/selling: DarioHealth (NASDAQ:DRIO)

In the past three months, DarioHealth insiders have not sold or bought any company stock. Only 21.20% of the stock of DarioHealth is held by insiders. Only 5.59% of the stock of DarioHealth is held by institutions.

Earnings and Valuation of DarioHealth (NASDAQ:DRIO

Earnings for DarioHealth are expected to grow in the coming year, from ($4.93) to ($3.06) per share. The P/E ratio of DarioHealth is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of DarioHealth is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. DarioHealth has a P/B Ratio of 1.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

More latest stories: here